Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia
Condition: Atypical Endometrial Hyperplasia Interventions: Drug: Megestrol Acetate; Device: Levonorgestrel-releasing Intrauterine System(LNG-IUS) Sponsors: Fudan University; Shanghai 6th People's Hospital; Zhejiang Cancer Hospital; Shanghai Changning Maternity& Infant Health Hospital Active, not recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2017 Category: Research Source Type: clinical trials
Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer
Condition: Endometrial Neoplasm Malignant Stage I Interventions: Drug: Megestrol Acetate; Device: Levonorgestrel-releasing Intrauterine System(LNG-IUS) Sponsor: Fudan University Active, not recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2017 Category: Research Source Type: clinical trials
Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia
Condition: Atypical Endometrial Hyperplasia Interventions: Drug: Megestrol Acetate; Device: Levonorgestrel-releasing Intrauterine System(LNG-IUS) Sponsors: Fudan University; Shanghai 6th People's Hospital; Zhejiang Cancer Hospital; Shanghai Changning Maternity& Infant Health Hospital Active, not recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2017 Category: Research Source Type: clinical trials
Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer
Condition: Endometrial Neoplasm Malignant Stage I Interventions: Drug: Megestrol Acetate; Device: Levonorgestrel-releasing Intrauterine System(LNG-IUS) Sponsor: Fudan University Active, not recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2017 Category: Research Source Type: clinical trials